Navigation Links
Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
Date:5/17/2010

PRINCETON, N.J., May 17 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today its financial results for the first quarter of 2010.

Soligenix's revenues for the first quarter of 2010 were approximately $336,000 as compared to $530,000 for the first quarter of 2009. The decreased revenues were primarily a result of decreases in National Institutes of Health (NIH) grant revenues as the Company reached the end of its earlier NIH grants before the work under its newer grants had commenced.

Soligenix's net loss for the first quarter of 2010 was approximately $2,136,000, or $(0.01) per share, as compared to $2,145,000, or $(0.01) per share, for the first quarter of 2009.

Research and development expenses for the first quarter of 2010 were approximately $1,598,000, compared to $1,591,000 for the first quarter of 2009. General and administrative expenses for the first quarter of 2010 were approximately $538,000, compared to $532,000 for the first quarter of 2009.

"Soligenix continues to make strong progress towards its goal of regulatory approval of orBec® in various forms of Graft-versus-Host disease (GVHD)," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix.  "We are looking forward to announcing data from our Phase 2 clinical trial of orBec® in the prevention of acute GVHD in the second half o
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
3. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
4. Soligenix Reports Third Quarter 2009 Financial Results
5. Soligenix to Present at 8th Annual BIO Investor Forum
6. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
7. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
8. Sinovac Reports Unaudited First Quarter 2010 Financial Results
9. Microbix Reports a Record Increase in Worldwide Sales for 2nd Quarter 2010
10. Transdel Pharmaceuticals Reports First Quarter 2010 Results
11. Aeterna Zentaris Reports First Quarter 2010 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Shimadzu Scientific Instruments today ... UV-visible spectrophotometer. Offering wavelength scanning from 190 to ... for applications in a variety of industries, including ... user-friendly UV-1280 enables intuitive operation, while the enhanced ...
(Date:1/22/2015)... 2015  Transwestern | RBJ today announces the firm brokered a ... Shire a leading biopharmaceutical company, at Two Ledgemont Center in ... Robert Richards , president, and Brian Cohen , senior ... five-floor building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... Protocol Networks brings independent technology consulting to the ... consultants, Protocol Networks has recently announced its expansion into ... his company has attracted several clients in The Constitution ... as others. With the success of these engagements, Rogers ...
(Date:1/22/2015)... zFlo Motion , a US leader ... exciting product from a new partner. STT-Systems has ... past 15 years, with offerings in the optical-motion capture, 3D ... system (inertial measurement unit), iSen, is opening eyes around the ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2
... Wis. - The Fitchburg Plan Commission has recommended approval ... building and data center that would accommodate the expansion of ... the anchor tenant in both buildings, which are planned for ... Fitchburg Technology Campus . , ,The plans, which now go ...
... hero, she was heading to the tiny island nation of ... Indian Ocean. By all reports and expectations, she would be off ... disconnection. , ,Or maybe not. After 36 hours in ... made our way through customs and out into the humid night ...
... - Tanya Townsend didn't have much time to pass the ... many other information technology directors have an opportunity to start ... and new processes? , ,Not many, and when the ... shopping for a chief technology executive in 2004, Townsend beat ...
Cached Biology Technology:Berbee to expand at New Venture Center 2Coveted vacation "disconnect" was elusive 2Coveted vacation "disconnect" was elusive 3CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 2CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 3CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 4CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 5
(Date:12/17/2014)... 15, 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a ... introduces for the first time a fingerprint sensor in ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... the power of 21st century computing to confirm an idea ... cycles evolve faster. Their findings appear in the October 3rd ... consequence for the understanding of evolution made possible by the ... said senior author Michael Donoghue , the G. Evelyn ...
... Using computer models and live cell experiments, biomedical engineers at ... than 100 human protein fragments that can slow or stop ... Reporting online last week in the Proceedings ... the findings could lead to developing treatments to fight diseases ...
... has confirmed the appointment of Esin Gulari, dean of the ... on the National Science Board (NSB). President George W. Bush ... scientists. "This is a tremendous honor for me as ... I will be in a unique position to make contributions ...
Cached Biology News:Reproducing early and often is the key to rapid evolution in plants 2Discovery of natural compounds that could slow blood vessel growth 2US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
One-step, colorimetric, linear detection range 0.7 mg/dL to 300 mg/dL. Procedure: 10 min....
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Recombinant Mouse LIGHT/TNFSF14...
Biology Products: